Second Opinions Have Little Impact on Prostate Cancer Decisions

Share this content:
Second opinions have little impact on prostate cancer patients' treatment decisions.
Second opinions have little impact on prostate cancer patients' treatment decisions.

(HealthDay News) -- Second opinions have little impact on prostate cancer patients' treatment decisions, according to findings published in Cancer.

The study included 2,386 men in the Philadelphia area recently diagnosed with localized prostate cancer. Forty percent of the men obtained a second opinion from urologists, most often because they wanted more information about their cancer (50.8 percent) or wanted to be seen by the best doctor (46.3 percent).

Overall, obtaining second opinions was not associated with changes in treatment choice or with improvements in how patients viewed their quality of cancer care. The researchers also found that patients who obtained second opinions because they wanted more information, were seeking the best doctor, or had been encouraged to do so by family or friends were more likely to undergo surgery.

RELATED: Prostate Biopsy Rates Drop Post-USPSTF 2012 PSA Screening Guidelines

This suggests that for some men, second opinions offer a way to pursue the treatment they already planned on, rather than to explore other treatment options, the study authors said in a journal news release.

Reference

  1. Radhakrishnan A, Grande D, Mitra N, et al. Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment. Cancer. 2016 Nov 7. doi: 10.1002/cncr.30412. [Epub ahead of print.]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters